Companies
/Healthcare
Progyny Inc
$36.58
▲ $0.08 (+0.22%) today
Markets closed · 4:43am ET
Progyny (PGNY) Earnings History & Trends
86%
EPS beat rate
−0.97%
Avg. EPS surprise
Consecutive EPS beats
PGNY vs Market · 30-day return after each reportPGNYS&P 500
PGNY EPS Trend · estimate vs actualEstimateActual
PGNY Revenue Trend · estimate vs actualEstimateActual
How Often Does Progyny Beat Earnings Estimates?
Progyny beat EPS estimates in 6 of its last 7 reported quarters, and has beaten 3 quarters in a row.
| Quarter | EPS · est. | Surprise | Revenue · est. | Surprise |
|---|---|---|---|---|
| Q3 2026 Adjusted EPS excludes stock-based compensation expense of $21,106 thousand, net of an income tax effect of $(5,155) thousand; GAAP diluted EPS was $0.32. | $0.52 est. $0.51 | +2.18% | $341.3M est. $340.8M | +0.14% |
| Q2 2026 | $0.55 est. $0.52 | +6.16% | $350.5M est. $348.6M | +0.53% |
| Q1 2026 | $0.50 est. $0.44 | +14.73% | $328.5M est. $326.5M | +0.61% |
| Q4 2025 | $0.14 est. $0.40 | −65.03% | $318.4M est. $314.3M | +1.32% |
| Q3 2025 | $0.45 est. $0.39 | +15.38% | $313.3M est. $299.2M | +4.72% |
| Q2 2025 | $0.48 est. $0.43 | +12.07% | $332.9M est. $320.1M | +3.99% |
| Q1 2025 | $0.48 est. $0.45 | +7.70% | $324.0M est. $307.8M | +5.27% |
Figures from SEC filings and company reports. Not investment advice.